KLF6 and TP53 Mutations Are a Rare Event in Prostate Cancer: Distinguishing Between Taq Polymerase Artifacts and True Mutations

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2008.145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TP53 Mutations Are Immunogenic in Epithelial Cancer

Cancer Discovery
Oncology
2019English

TP53 Mutations in Nonsmall Cell Lung Cancer

Journal of Biomedicine and Biotechnology
2011English

Mutations at Codon 974 of the DPYD Gene Are a Rare Event

British Journal of Cancer
Cancer ResearchOncology
1997English

TP53 Mutations Promote Immunogenic Activity in Breast Cancer

Journal of Oncology
Oncology
2019English

Germline PTEN Mutations Are Rare and Highly Penetrant

Hereditary Cancer in Clinical Practice
OncologyGenetics
2006English

TP53 Somatic Mutations Are Associated With Somatic Mitogenome Substitutions but Not Indels in Colorectal Cancer Cells

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2018English

Taq-Polymerase

2018English

A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics
Genetics
2010English

Germline TP53 and MSH6 Mutations Implicated in Sporadic Triple-Negative Breast Cancer (TNBC): A Preliminary Study

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy